Dialysis Filter Articles & Analysis
8 news found
There are currently 3.3 million haemodialysis patients worldwide who receive treatment multiple times a week. Dialysis treatment can reduce life expectancy by two thirds and almost half of patients die from cardiovascular complications, in part caused by the immune system reacting to components of the dialysis apparatus. The H-Guard Priming Solution comprises a ...
These figures are increasing due to rising incidence of chronic kidney disease, diabetes and acute kidney injury. Haemodialysis and Peritoneal Dialysis are the two main treatment methods used today. Both have limitations due to the body’s immune reaction to the procedure. Today Invizius is developing its H-Guard Haemodialysis Priming Solution which comprises a novel ...
This novel synthetic blood vessel, based on our proprietary STAR biomaterial technology, has the potential to improve the lives of dialysis patients by reducing the frequency & severity of infections and the frequency of interventions required to maintain dialysis access." About Vascular Grafts More than 500,000 people in the United States suffer from kidney ...
For particularly ill patients with COVID-19, the virus can cause acute kidney failure which can eventually turn into chronic kidney failure – with the only treatment options being either lifelong dialysis or a kidney transplant. The H-Guard Priming Solution comprises a novel protein that lines the inside of the dialysis filter and helps ...
As market leader in sulfone polymers, Solvay provides pure, biocompatible specialty polymers used in the production of dialysis filters. In addition to its internal R&D efforts, investments in ground-breaking start-ups like Invizius advances Solvay’s commitment to serving this market to help increase life expectancy and survival rate for millions of ...
Invizius, the University of Edinburgh spin-out whose technology could help reduce the high death rates amongst dialysis patients, has raised £2.75m from a consortium of investors. ...
About Vascular Grafts More than 500,000 people in the United States suffer from kidney failure and require frequent dialysis to filter waste from their blood. Current methods of creating and maintaining regular bloodstream access for dialysis are unreliable and account for a significant portion of the $50 billion spent each year on U.S. kidney ...
Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications, and life expectancy on dialysis is just one-third of that for the general population. The patient’s immune system sees ...